Association between -308 G/A TNF- α polymorphism and appendicular skeletal muscle mass index as a marker of sarcopenia in normal weight obese syndrome

Disease Markers

Volumn 35, Issue 6, 2013, Pages 615-623

  Di Renzo, L ^a   Sarlo, F ^a   Petramala, L ^a   Iacopino, L ^a   Monteleone, G ^a   Colica, C ^b   De Lorenzo, A ^a,c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c INDiM   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTHROPOMETRIC PARAMETERS; APPENDICULAR SKELETAL MUSCLE MASS INDEX; ARTICLE; BLOOD ANALYSIS; BODY COMPOSITION; BODY MASS; DNA POLYMORPHISM; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HOMOZYGOTE; HUMAN; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; NORMAL WEIGHT OBESE SYNDROME; OBESITY; PRIORITY JOURNAL; PROMOTER REGION; SARCOPENIA; SKELETAL MUSCLE; WILD TYPE;

ADIPOSITY; ADULT; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; MUSCLE, SKELETAL; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; SARCOPENIA; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84888884505     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2013/983424     Document Type: Article

References (50)

1. Coin A., Sarti S., Ruggiero E., Prevalence of sarcopenia based on different diagnostic criteria using DEXA and appendicular skeletal muscle mass reference values in an Italian population aged 20 to 80. Journal of the American Medical Directors Association 2013 10.1016/j.jamda.2013.02.010
2. Gloria-Bottini F., Cervelli V., Giarrizzo G. F., Martinoli R., Di Renzo L., De Lorenzo A., Sex differences in body fat parameters from the early reproductive to the postreproductive period of life: a multivariate analysis. Human Biology 2007 79 4 373 379 2-s2.0-36349035253
3. Frühbeck G., Hunting for new pieces to the complex puzzle of obesity. Proceedings of the Nutrition Society 2006 65 329 347
4. Rankinen T., Zuberi A., Chagnon Y. C., Weisnagel S. J., Argyropoulos G., Walts B., Pérusse L., Bouchard C., The human obesity gene map: the 2005 update. Obesity 2006 14 4 529 644 2-s2.0-33749017409 10.1038/oby.2006.71
5. Cruz-Jentoft A. J., Baeyens J. P., Bauer J. M., Boirie Y., Cederholm T., Landi F., Martin F. C., Michel J.-P., Rolland Y., Schneider S. M., Topinková E., Vandewoude M., Zamboni M., Sarcopenia: European consensus on definition and diagnosis. Age and Ageing 2010 39 4 412 423 2-s2.0-77953870112 10.1093/ageing/afq034 afq034
6. Silva A. O., Karnikowski M. G., Funghetto S. S., Association of body composition with sarcopenic obesity in elderly women. International Journal of General Medicine 2013 6 25 29 10.2147/IJGM.S36279
7. de Lorenzo A., di Renzo L., Puja A., Saccucci P., Gloria-Bottini F., Bottini E., A study of acid phosphatase locus 1 in women with high fat content and normal body mass index. Metabolism 2009 58 3 351 354 2-s2.0-59649097246 10.1016/j.metabol.2008.10.007
8. Romero-Corral A., Somers V. K., Sierra-Johnson J., Thomas R. J., Collazo-Clavell M. L., Korinek J., Allison T. G., Batsis J. A., Sert-Kuniyoshi F. H., Lopez-Jimenez F., Accuracy of body mass index in diagnosing obesity in the adult general population. International Journal of Obesity 2008 32 6 959 966 2-s2.0-47249093665 10.1038/ijo.2008.11
9. World Health Organization, Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organization Technical Reports Series 1995 854 1 452
10. Chung J. Y., Kang H. T., Lee D. C., Lee H. R., Lee Y. J., Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity. Archives of Gerontology and Geriatrics 2013 56 1 270 278 10.1016/j.archger.2012.09.007
11. di Monaco M., Vallero F., Di Monaco R., Tappero R., Prevalence of sarcopenia and its association with osteoporosis in 313 older women following a hip fracture. Archives of Gerontology and Geriatrics 2011 52 1 71 74 2-s2.0-78649697897 10.1016/j.archger.2010.02.002
12. de Lorenzo A., Deurenberg P., Pietrantuono M., Di Daniele N., Cervelli V., Andreoli A., How fat is obese? Acta Diabetologica 2003 40 1 S254 S257 2-s2.0-0142209215 10.1007/s00592-003-0079-x
13. Hsu F.-C., Lenchik L., Nicklas B. J., Lohman K., Register T. C., Mychaleckyj J., Langefeld C. D., Freedman B. I., Bowden D. W., Carr J. J., Heritability of body composition measured by DXA in the Diabetes Heart Study. Obesity Research 2005 13 2 312 319 2-s2.0-23044444928
14. de Lorenzo A., Bianchi A., Maroni P., Iannarelli A., Di Daniele N., Iacopino L., Di Renzo L., Adiposity rather than BMI determines metabolic risk. International Journal of Cardiology 2011 166 1 111 117 2-s2.0-80855127917 10.1016/j.ijcard.2011.10.006
15. De Lorenzo A., Martinoli R., Vaia F., Di Renzo L., Normal weight obese (NWO) women: an evaluation of a candidate new syndrome. Nutrition, Metabolism and Cardiovascular Diseases 2006 16 8 513 523 2-s2.0-33749133898 10.1016/j.numecd.2005.10.010
16. De Lorenzo A., Del Gobbo V., Premrov M. G., Bigioni M., Galvano F., Di Renzo L., Normal-weight obese syndrome: early inflammation? American Journal of Clinical Nutrition 2007 85 1 40 45 2-s2.0-33846087022
17. Di Renzo L., Galvano F., Orlandi C., Bianchi A., Di Giacomo C., La Fauci L., Acquaviva R., De Lorenzo A., Oxidative stress in normal-weight obese syndrome. Obesity 2010 18 11 2125 2130 2-s2.0-78049260011 10.1038/oby.2010.50
18. Di Renzo L., Del Gobbo V., Bigioni M., Premrov M. G., Cianci R., De Lorenzo A., Body composition analyses in normal weight obese women. European Review for Medical and Pharmacological Sciences 2006 10 4 191 196 2-s2.0-33748555194
19. Di Renzo L., Noce A., De Angelis S., Miani N., Di Daniele N., Tozzo C., De Lorenzo A., Anti-inflammatory effects of combined treatment with acetyl salicylic acid and atorvastatin in haemodialysis patients affected by Normal Weight Obese syndrome. Pharmacological Research 2008 57 2 93 99 2-s2.0-40149087164 10.1016/j.phrs.2007.11.005
20. Marques-Vidal P., Pécoud A., Hayoz D., Paccaud F., Mooser V., Waeber G., Vollenweider P., Prevalence of normal weight obesity in Switzerland: effect of various definitions. European Journal of Nutrition 2008 47 5 251 257 2-s2.0-48749089948 10.1007/s00394-008-0719-6
21. Marques-Vidal P., Pécoud A., Hayoz D., Paccaud F., Mooser V., Waeber G., Vollenweider P., Normal weight obesity: relationship with lipids, glycaemic status, liver enzymes and inflammation. Nutrition, Metabolism and Cardiovascular Diseases 2010 20 9 669 675 2-s2.0-78049358725 10.1016/j.numecd.2009.06.001
22. Romero-Corral A., Somers V. K., Sierra-Johnson J., Korenfeld Y., Boarin S., Korinek J., Jensen M. D., Parati G., Lopez-Jimenez F., Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. European Heart Journal 2010 31 6 737 746 2-s2.0-77951960109 10.1093/eurheartj/ehp487
23. Di Renzo L., Bigioni M., Bottini F. G., Del Gobbo V., Premrov M. G., Cianci R., De Lorenzo A., Normal weight obese syndrome: role of single nucleotide polymorphism of IL-15R α and MTHFR 677C→T genes in the relationship between body composition and resting metabolic rate. European Review for Medical and Pharmacological Sciences 2006 10 5 235 245 2-s2.0-33845587188
24. Di Renzo L., Bigioni M., Del Gobbo V., Premrov M. G., Barbini U., Di Lorenzo N., De Lorenzo A., Interleukin-1 (IL-1) receptor antagonist gene polymorphism in normal weight obese syndrome: relationship to body composition and IL-1 α and β plasma levels. Pharmacological Research 2007 55 2 131 138 2-s2.0-33846574357 10.1016/j.phrs.2006.11.002
25. Di Renzo L., Bertoli A., Bigioni M., Del Gobbo V., Premrov M. G., Calabrese V., Di Daniele N., De Lorenzo A., Body composition and -174G/C interleukin-6 promoter gene polymorphism: association with progression of insulin resistance in normal weight obese syndrome. Current Pharmaceutical Design 2008 14 26 2699 2706 2-s2.0-57349134914 10.2174/138161208786264061
26. Argilés J. M., López-Soriano J., Almendro V., Busquets S., López-Soriano F. J., Cross-talk between skeletal muscle and adipose tissue: a link with obesity? Medicinal Research Reviews 2005 25 1 49 65 2-s2.0-10344245516 10.1002/med.20010
27. Frühbeck G., Gómez-Ambrosi J., Muruzábal F. J., The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. American Journal of Physiology: Endocrinology and Metabolism 2001 280 E827 E847
28. Nedwin G. E., Naylor S. L., Sakaguchi A. Y., Smith D., Jarrett-Nedwin J., Pennica D., Goeddel D. V., Gray P. W., Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Research 1985 13 17 6361 6373 2-s2.0-0022423546 10.1093/nar/13.17.6361
29. Wilson A. G., Symons J. A., Mcdowell T. L., Mcdevitt H. O., Duff G. W., Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proceedings of the National Academy of Sciences of the United States of America 1997 94 7 3195 3199 2-s2.0-0030954180 10.1073/pnas.94.7.3195
30. Cervelli V., Di Renzo L., Grimaldi M., Chiara Di Fede M., Gentile P., Gravante G., di Lorenzo N., De Lorenzo A., Dual Energy X-Ray Absorptiometry in pre-obese/obese women undergoing reduction mammaplasty. Journal of Plastic, Reconstructive and Aesthetic Surgery 2009 62 6 e187 e189 2-s2.0-67349261969 10.1016/j.bjps.2008.07.027
31. Fernández-Real J. M., Gutierrez C., Ricart W., Casamitjana R., Fernández-Castañer M., Vendrell J., Richart C., Soler J., The TNF- α gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes 1997 46 9 1468 1472 2-s2.0-0030863239
32. Shuldiner A. R., Obesity genes and gene-environment-behavior interactions: recommendations for a way forward. Obesity 2008 16 3 S79 S81 2-s2.0-56849097270 10.1038/oby.2008.523
33. Shah N. R., Braverman E. R., Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptin. PLoS ONE 2012 7 4 2-s2.0-84859224327 10.1371/journal.pone.0033308 e33308
34. Wormser D., Kaptoge S., Di Angelantonio E., Wood A. M., Pennells L., Thompson A., Sarwar N., Kizer J. R., Lawlor D. A., Nordestgaard B. G., Ridker P., Salomaa V., Stevens J., Woodward M., Sattar N., Collins R., Thompson S. G., Whitlock G., Danesh J., Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. The Lancet 2011 377 9771 1085 1095 2-s2.0-79953163759 10.1016/S0140-6736(11)60105-0
35. Madeira F. B., Silva A. A., Veloso H. F., Normal weight obesity is associated with metabolic syndrome and insulin resistance in young adults from a middle-income country. PLoS ONE 2013 8 3 e60673 10.1371/journal.pone.0060673
36. Argilés J. M., López-Soriano J., Busquets S., López-Soriano F. J., Journey from cachexia to obesity by TNF. FASEB Journal 1997 11 10 743 751 2-s2.0-0343742637
37. Feinstein R., Kanety H., Papa M. Z., Lunenfeld B., Karasik A., Tumor necrosis factor- α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. Journal of Biological Chemistry 1993 268 35 26055 26058 2-s2.0-0027332738
38. Hedayati M., Sharifi K., Rostami F., Daneshpour M. S., Zarif Yeganeh M., Azizi F., Association between TNF- α promoter G-308A and G-238A polymorphisms and obesity. Molecular Biology Reports 2012 39 2 825 829 2-s2.0-84860316320 10.1007/s11033-011-0804-4
39. Romeo S., Sentinelli F., Capici F., Arca M., Berni A., Vecci E., Di Mario U., Baroni M. G., The G-308A variant of the Tumor Necrosis Factor- α (TNF- α) gene is not associated with obesity, insulin resistance and body fat distribution. BMC Medical Genetics 2001 2, article 10 2-s2.0-0011819732 10.1186/1471-2350-2-10
40. Rasmussen S. K., Urhammer S. A., Jensen J. N., Hansen T., Borch-Johnsen K., Pedersen O., The -238 and -308 G→A polymorphisms of the tumor necrosis factor α gene promotor are not associated with features of the insulin resistance syndrome or altered birth weight in Danish Caucasians. Journal of Clinical Endocrinology and Metabolism 2000 85 4 1731 1734 2-s2.0-0034456128 10.1210/jc.85.4.1731
41. Sookoian S. C., González C., Pirola C. J., Meta-analysis on the G308A TNF alpha gene variant and phenotypes associated with Metaboic sindrome. Obesity Research 2005 13 2122 2130
42. de Luis D. A., Aller R., Izaola O., González Sagrado M., Conde R., de la Fuente B., Ovalle H. F., Allelic frequency of G380A polymorphism of tumor necrosis factor alpha gene and relation with cardiovascular risk factors and adipocytokines in obese patients. Nutricion Hospitalaria 2011 26 4 711 715 2-s2.0-79960676355 10.3305/nh.2011.26.4.5204
43. Chen S.-E., Jin B., Li Y.-P., TNF- α regulates myogenesis and muscle regeneration by activating p38 MAPK. American Journal of Physiology: Cell Physiology 2007 292 5 C1660 C1671 2-s2.0-34250669605 10.1152/ajpcell.00486.2006
44. Guttridge D. C., Mayo M. W., Madrid L. V., Wang C.-Y., Baldwin A.S. J., NF- B-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 2000 289 5488 2363 2365 2-s2.0-0034730251 10.1126/science.289. 5488.2363
45. Adhikari A., Xu M., Chen Z. J., Ubiquitin-mediated activation of TAK1 and IKK. Oncogene 2007 26 22 3214 3226 2-s2.0-34248570795 10.1038/sj.onc.1210413
46. Li Y., Jiang B.-H., Ensign W. Y. Jr., Vogt P. K., Han J., Myogenic differentiation requires signalling through both phosphatidylinositol 3-kinase and p38 MAP kinase. Cellular Signalling 2000 12 11-12 751 757 2-s2.0-0034528405 10.1016/S0898-6568(00)00120-0
47. Trendelenburg A. U., Meyer A., Jacobi C., TAK-1/p38/nNF B signaling inhibits myoblast differentiation by increasing levels of Activin A. Skeletal Muscle 2012 2 1, article 3 10.1186/2044-5040-2-3
48. Kollias H. D., Perry R. L. S., Miyake T., Aziz A., McDermott J. C., Smad7 promotes and enhances skeletal muscle differentiation. Molecular and Cellular Biology 2006 26 16 6248 6260 2-s2.0-33747006700 10.1128/MCB.00384-06
49. Srivastava A. K., Qin X., Wedhas N., Arnush M., Linkhart T. A., Chadwick R. B., Kumar A., Tumor necrosis factor- augments matrix metalloproteinase-9 production in skeletal muscle cells through the activation of transforming growth factor- β -activated kinase 1 (TAK1)-dependent signaling pathway. Journal of Biological Chemistry 2007 282 48 35113 35124 2-s2.0-36849092777 10.1074/jbc.M705329200
50. Roubenoff R., Catabolism of aging: is it an inflammatory process? Current Opinion in Clinical Nutrition and Metabolic Care 2003 6 3 295 299 2-s2.0-0037927688 10.1097/00075197-200305000-00005